These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 3668356

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Significance of the cellular infiltrate at the host-tumor borderline in endometrial adenocarcinoma].
    Shapira I, Griffel B.
    Harefuah; 1984 Jun 01; 106(11):490-2. PubMed ID: 6479701
    [No Abstract] [Full Text] [Related]

  • 23. Problems in the treatment of endometrial carcinoma.
    Grönroos M, Punnonen R, Rauramo L, Laurén P.
    Ann Chir Gynaecol Fenn; 1974 Jun 01; 63(2):141-5. PubMed ID: 4853782
    [No Abstract] [Full Text] [Related]

  • 24. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma.
    Connelly PJ, Alberhasky RC, Christopherson WM.
    Obstet Gynecol; 1982 May 01; 59(5):569-75. PubMed ID: 7070727
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [A study of factors affecting prognosis of endometrial cancer (author's transl)].
    Yoshida S, Nakajima H, Matsumoto Y, Yamabe T.
    Nihon Gan Chiryo Gakkai Shi; 1978 Apr 20; 13(2):95-101. PubMed ID: 659941
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G, Kenda R, Andreola S, Luciani L, Musumeci R, Rilke F.
    Obstet Gynecol; 1982 Aug 20; 60(2):225-31. PubMed ID: 7155485
    [Abstract] [Full Text] [Related]

  • 29. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA.
    Obstet Gynecol; 1988 Sep 20; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [Abstract] [Full Text] [Related]

  • 30. [Prognostic significance of the length of the uterus, depth of infiltration and grading of endometrium cancer].
    Elling D, Schildhaus I, Götze W, Bartel U.
    Zentralbl Gynakol; 1990 Sep 20; 112(2):75-9. PubMed ID: 2316298
    [Abstract] [Full Text] [Related]

  • 31. [Preoperative diagnosis for stage II endometrial carcinoma using endocervical conization].
    Fukuda K, Masubuchi S, Masubuchi K.
    Gan No Rinsho; 1984 Jul 20; 30(8):933-6. PubMed ID: 6471397
    [Abstract] [Full Text] [Related]

  • 32. [Histopathology and morphologic prognostic criteria in endometrial cancer].
    Schrodt U.
    Zentralbl Gynakol; 1987 Jul 20; 109(7):425-31. PubMed ID: 3617989
    [Abstract] [Full Text] [Related]

  • 33. New aspects of endometrial carcinoma.
    Silverberg SG.
    Clin Obstet Gynaecol; 1984 Apr 20; 11(1):189-208. PubMed ID: 6370532
    [Abstract] [Full Text] [Related]

  • 34. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB.
    Obstet Gynecol; 1973 Jan 20; 41(1):129-36. PubMed ID: 4682608
    [No Abstract] [Full Text] [Related]

  • 35. [Histomorphologic prognostic factors in stage I endometrial cancers].
    Köhler U, Bilek K, Rosenkranz M.
    Zentralbl Gynakol; 1987 Jan 20; 109(20):1245-54. PubMed ID: 3425025
    [Abstract] [Full Text] [Related]

  • 36. [Endometrial carcinoma--stage I. Evaluation of risk and prognostic factors in an analysis of 120 cases].
    Romano FM, Bruno G, Manicastri AM.
    Minerva Ginecol; 1991 Mar 20; 43(3):97-104. PubMed ID: 2057108
    [Abstract] [Full Text] [Related]

  • 37. [Morphologic prognostic criteria in endometrial cancer with special reference to nuclear grading].
    Schneider ML.
    Geburtshilfe Frauenheilkd; 1986 May 20; 46(5):267-77. PubMed ID: 3721157
    [Abstract] [Full Text] [Related]

  • 38. Prognostic factors in endometrial carcinoma.
    De Mûelenaere GF.
    S Afr Med J; 1975 Sep 27; 49(41):1695-8. PubMed ID: 1179240
    [Abstract] [Full Text] [Related]

  • 39. Morphometric analysis of endometrial adenocarcinoma: 2. A comparison of architectural differentiation determined morphometrically with subjective grading.
    Zaino RJ, Laskaris A, Whitney C, Sharkey FE.
    Int J Gynecol Pathol; 1987 Sep 27; 6(1):20-8. PubMed ID: 3570629
    [Abstract] [Full Text] [Related]

  • 40. [Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma].
    Ren YL, Wang HY, Zhou XY, Shan BE, Yang WT, Shen L, Shi DR.
    Zhonghua Fu Chan Ke Za Zhi; 2010 May 27; 45(5):367-71. PubMed ID: 20646447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.